AFG Earnings Preview: Analysts Split as Co-CEO Sells

American Financial Group reports Q3 2026 results on November 3, trading at $153.87, roughly in line with the Street's mean price target of $154.50.

Among its closest P&C insurance peers, AFG is neither the most crowded short nor the least. CB and ACGL each carry heavier short positioning relative to float. AFG's own short interest is modest at 2.2% of free float, up 6% over the past week and 16% over the past month, though the absolute level remains low. The borrow market tells a similar story of indifference: availability is effectively unconstrained, with lending pool capacity running at more than 9,000% of current short interest, and the cost to borrow has fallen 27% over the past week to just 0.30%. Shorts face no squeeze pressure whatsoever. Options confirm the relaxed tone, with the put/call ratio at 0.15, barely above its 20-day average and near the lowest readings of the past year. The stock itself has gained 11% over the past month and 2.2% on the week, ahead of a peer median of roughly 0.6%.

The analyst community heading into the print is more cautious than the price action implies. Wells Fargo trimmed its target from $175 to $166 on October 12, maintaining Overweight, while Keefe, Bruyette & Woods cut its Market Perform target from $153 to $147 on the same day. Both moves came ahead of the report, and both put their revised targets below where the stock now trades at $153.87. The bull case rests on AFG's second-quarter momentum: reported EPS of $2.82 beat consensus of $2.37, specialty combined ratio came in at 91.5% with 3.3 points of favorable reserve development, and net investment income grew 23.5%. Bears point to decelerating renewal pricing across Specialty Casualty and Specialty Financial, with overall Specialty P&C renewal rates at plus 5% versus plus 7% a year earlier, and a rising expense ratio tied to lender-placed insurance growth.

The insider register adds a layer of complexity. Co-CEO Carl Lindner III sold approximately $13 million of stock in late August at prices around $144, with no 10b5-1 plan attached, a discretionary sale made below the stock's current level. The CFO and General Counsel each made smaller open-market sales in August and September. On the other side, both S. Craig Lindner and Carl H. Lindner III appear on the SEC 13D register as activist-designated holders, each disclosing stakes above 6% as of April 2026. The Lindner family's combined presence as both sellers and Schedule 13D filers underscores how tightly controlled the company remains. Separately, Vanguard filed a 13G/A in March 2026 showing its stake had fallen to zero from 8.74% previously, a significant ownership shift worth noting. As always with 13D/G disclosures, positions are as-last-disclosed around the 5% threshold and holders dropping below that level may exit without a further filing.

The print is effectively a test of whether AFG's Q2 beat was the start of a durable re-acceleration or a high-water mark as pricing momentum moderates and expenses rise across the specialty book.